3-(4-Chlorobenzyl)-5-((4-(4-fluorophenyl)thiazol-2-yl)methyl)-1,2,4-oxadiazole结构式
|
常用名 | 3-(4-Chlorobenzyl)-5-((4-(4-fluorophenyl)thiazol-2-yl)methyl)-1,2,4-oxadiazole | 英文名 | 3-(4-Chlorobenzyl)-5-((4-(4-fluorophenyl)thiazol-2-yl)methyl)-1,2,4-oxadiazole |
|---|---|---|---|---|
| CAS号 | 1112360-84-5 | 分子量 | 385.8 | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | C19H13ClFN3OS | 熔点 | N/A | |
| MSDS | N/A | 闪点 | N/A |
| 英文名 | 3-(4-Chlorobenzyl)-5-((4-(4-fluorophenyl)thiazol-2-yl)methyl)-1,2,4-oxadiazole |
|---|
| 分子式 | C19H13ClFN3OS |
|---|---|
| 分子量 | 385.8 |
| InChIKey | QINWHMLTOGBFPV-UHFFFAOYSA-N |
| SMILES | Fc1ccc(-c2csc(Cc3nc(Cc4ccc(Cl)cc4)no3)n2)cc1 |
|
实验名称:High-throughput screen for inhibitors of the GIV GBA-motif interaction with Galpha-i ...
来源:ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
External Id:HMS1303
|